NCT00629343 2025-06-05
Phase I Dose-Escalation Study Of Azacitidine In Combination With Temozolomide
Columbia University
Phase 1 Completed
Columbia University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Albert Einstein College of Medicine
Loma Linda University
University of Miami